PARIS, France—Patients who take ticagrelor after ACS are no more likely to experience a major bleeding event than patients who take clopidogrel, results of the ROBOT-ACS study suggest. The data, ...
Please provide your email address to receive an email when new articles are posted on . In patients with ACS who had angioplasty and stenting, ticagrelor monotherapy after 1 month reduced bleeding vs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results